<DOC>
	<DOC>NCT00509106</DOC>
	<brief_summary>The purpose of the study is to determine if the antibiotic ceftaroline is safe and effective in the treatment of community-acquired pneumonia in adults.</brief_summary>
	<brief_title>Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia</brief_title>
	<detailed_description>Clinical trials is being held in different countries. The purpose of the study is to determine if the antibiotic ceftaroline is safe and effective in the treatment of community-acquired pneumonia in adults.</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia, Bacterial</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Subjects with communityacquired pneumonia requiring: initial hospitalization or treatment in an emergency room or urgent care setting infection requiring initial treatment with IV antimicrobial Communityacquired pneumonia suitable for outpatient therapy with an oral antimicrobial agent Respiratory tract infections not due to communityacquired bacterial pathogens Infections resistant to ceftriaxone Any condition requiring concomitant systemic corticosteroids History of any hypersensitivity or allergic reaction to any ÃŸlactam antimicrobial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ceftaroline</keyword>
	<keyword>Community-acquired pneumonia</keyword>
	<keyword>CAP</keyword>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>Haemophilus influenzae</keyword>
	<keyword>Mycoplasma pneumoniae</keyword>
	<keyword>Chlamydophila spp</keyword>
	<keyword>Legionella ssp</keyword>
	<keyword>multi-drug resistant Streptococcus pneumoniae (MDRSP)</keyword>
	<keyword>antimicrobial resistance</keyword>
	<keyword>pneumococci</keyword>
	<keyword>beta-lactam</keyword>
	<keyword>ceftaroline fosamil</keyword>
	<keyword>ceftriaxone</keyword>
	<keyword>antibiotic</keyword>
</DOC>